Background: The goal of treatment for anal squamous cell carcinoma (ASCC) is to preserve a functional anal sphincter and maintain the best quality of life. Surgical excision is reserved only for very early stages, and concomitant chemoradiotherapy (CHRT) is usually used in the treatment of ASCC. The aim of the study is a retrospective analysis of a group of patients with ASCC treated with CHRT using accelerated radiotherapy at the Institute of Radiation Oncology of Bulovka University Hospital in Prague (IRO BUH).
Patients And Methods: Between 2014 and 2022, 73 patients with ASCC underwent definitive CHRT. Patients were treated with accelerated radiotherapy in 25 fractions - to the tumor and affected lymph nodes at 2.3 Gy to a dose of 57.5 Gy and to the area of the lymphatics at 1.8 Gy to a dose of 45 Gy. Concomitant chemotherapy mitomycin + 5-fluorouracil, later mitomycin + capecitabine was administered.
Results: A total of 64 (87.7%) patients underwent CHRT, in the remaining 9 (12.3%) cases only radiotherapy was applied. The 2- and 5-year overall survival rates were 85.8% and 76.3%, disease-free survival 88.0% and 86.3%, local control 91.9% and 91.9%, and colostomy-free interval 68.5% and 68.5%, respectively. The median of these parameters was not reached. Acute toxicity grade G3-4 was reported in 51 (69.8%) patients, late toxicity G3-4 was detected in 10 (13.7%) cases. No grade 5 toxicity occurred.
Conclusion: Accelerated radiotherapy in the treatment of ASCC resulted in favorable disease control but was burdened with significant toxicity.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.48095/ccko2024335 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous HO- and O-independent ROS generation.
Nat Commun
January 2025
State Key Lab of Metal Matrix Composites School of Materials Science and Engineering Shanghai Jiao Tong University 800 Dongchuan Road, Shanghai, P. R. China.
Reactive oxygen species with evoked immunotherapy holds tremendous promise for cancer treatment but has limitations due to its dependence on exogenous excitation and/or endogenous HO and O. Here we report a versatile oxidizing pentavalent bismuth(V) nanoplatform (NaBiO-PEG) can generate reactive oxygen species in an excitation-free and HO- and O-independent manner. Upon exposure to the tumor microenvironment, NaBiO-PEG undergoes continuous H-accelerated hydrolysis with •OH and O generation through electron transfer-mediated Bi-to-Bi conversion and lattice oxygen transformation.
View Article and Find Full Text PDFGlobal linear accelerator requirements and personalised country recommendations: a cross-sectional, population-based study.
Lancet Oncol
January 2025
Ribeirão Preto Medical School, Department of Medical Imaging, Haematology and Oncology, University of São Paulo, São Paulo, Brazil.
Background: The Linear Accelerator Shortage Index (LSI) is a practical tool for prioritising the deployment of linear accelerators (LINACs) in various regions within a country. The LSI reflects the ratio of LINAC demand to current availability. The aim of this study was to use the LSI to predict global LINAC needs and classify countries according to the degree of radiotherapy shortage (LINAC shortage grade).
View Article and Find Full Text PDFConventional chemoradiation versus accelerated chemoradiation: A prospective study in oropharyngeal cancer.
Natl J Maxillofac Surg
November 2024
Department of Head and Neck (Oral and Maxillofacial Surgery), Kalyan Singh Super Speciality Cancer Institute, Lucknow, Uttar Pradesh, India.
Background: Squamous-cell carcinoma of the head and neck is predominantly a loco regional disease, and the primary treatment methods are surgery and radiotherapy. For patients with locally-regionally advanced oropharyngeal cancer, concurrent chemoradiotherapy is the standard treatment.
Material And Method: The aim and objectives of study were a) to compare locoregional response in two arms, b) to compare acute and chronic treatment-related toxicities in the two arms, and c) to compare the quality of life.
"Nanoparticle-based sensitizers in prostate cancer treatment: Enhancing radiotherapy efficacy through innovative nanotechnology: Narrative review".
Appl Radiat Isot
January 2025
Behbahan Faculty of Medical Sciences, Behbahan, Iran. Electronic address:
For men with localized prostate cancer, radiotherapy (RT) remains a common therapeutic option. Although radiotherapy has had significant success, it remains an intractable issue in promoting radiation damage to tumor tissue while reducing adverse effects on healthy tissue. Chemicals or pharmacological substances known as radiosensitizers can increase the killing effect on tumor cells by accelerating DNA damage and indirectly producing free radicals.
View Article and Find Full Text PDFEvaluating the impact of COVID-19 protection measures and staff absence on radiotherapy practice: A simulation study.
PLoS One
January 2025
Faculty of Management and Technology, Leuphana University, Lüneburg, Germany.
Background: Radiotherapy practice for cancer treatment is resource-intensive and demands optimised processes for patient throughput while guaranteeing the quality and safety of the therapy. With the COVID-19 pandemic, ad-hoc changes in the operation of radiotherapy centres became necessary to protect patients and staff. This simulation study aimed to quantify the impact of designated COVID-19 protection measures and pandemic-related staff absence on patient waiting times and throughput.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!